Comments on: Shirovasti Therapy Deep Dive: Neurological and Psychiatric Indications

By: Jason Miller

Jason Miller — Thu, 14 Jan 2027 14:19:16 +0000

Seems like a very specialized therapy, and I wonder how practical it is outside bigger Ayurvedic centers. The setup, oil selection, and monitoring sound pretty involved for routine use.

By: Karen Phillips

Karen Phillips — Mon, 04 Jan 2027 00:28:38 +0000

The schizophrenia section caught my attention, but the mechanism felt a little speculative. PANSS changes are useful, though it would be nice to know how durable the results are after the 28 day window.

By: Rebecca Turner

Rebecca Turner — Wed, 23 Dec 2026 21:42:13 +0000

I appreciate that the article mentioned evidence, but some of those studies still feel small. A trial with 32 patients is interesting, yet I would want to see larger multicenter work before calling it strong proof.

By: Ashley Carter

Ashley Carter — Sun, 13 Dec 2026 03:46:40 +0000

How is this usually chosen in clinics for someone with anxiety versus chronic insomnia? The article mentions both, but I was curious whether the oil and session length change much based on the main symptom.

By: Jessica Reed

Jessica Reed — Wed, 02 Dec 2026 06:28:27 +0000

The safety notes matter a lot. Keeping the oil in that 38 to 42 C range sounds simple, but in real practice that kind of temperature control probably makes a big difference.

By: Nicole Hayes

Nicole Hayes — Sat, 21 Nov 2026 01:00:10 +0000

not something I had looked into before, but the connection between classical Ayurvedic indications and newer clinical trials was pretty clear here. The comparison with shirodhara also helped put the differences in context.

By: Mark Bennett

Mark Bennett — Tue, 10 Nov 2026 03:44:43 +0000

The mechanism section was the most convincing part to me. Seeing the discussion of lipid soluble compounds, scalp absorption, and CSF transfer makes the therapy feel a lot less vague than people usually assume.

By: Emily Foster

Emily Foster — Fri, 30 Oct 2026 10:23:29 +0000

Interesting read on how shirovasti is being framed for nerve and brain related conditions. The facial palsy data stood out, especially the part about faster House Brackmann improvement with the combined protocol.